圣诺医药-B(02257)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

02257 圣诺医药-B

已收盘 07-22 16:08:56

4.740

+0.030

+0.64%

最高4.880	最低4.660	成交量50.56万
今开4.790	昨收4.710	日振幅4.67%
总市值4.15亿	流通市值4.15亿	总股本8,764万
成交额240.67万	换手率0.58%	流通股本8,764万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"02257","market":"HK","secType":"STK","nameCN":"圣诺医药-B","latestPrice":4.74,"timestamp":1721635736030,"preClose":4.71,"halted":0,"volume":505600,"delay":0,"floatShares":87638480,"shares":87638480,"eps":-8.078138,"marketStatus":"已收盘","marketStatusCode":5,"change":0.03,"latestTime":"07-22 16:08:56","open":4.79,"high":4.88,"low":4.66,"amount":2406700,"amplitude":0.046709,"askPrice":4.78,"askSize":1700,"bidPrice":4.74,"bidSize":12250,"shortable":0,"etf":0,"ttmEps":-8.078138663335416,"exchange":"SEHK","tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1721698200000},"adr":0,"listingDate":1640793600000,"adjPreClose":4.71,"openAndCloseTimeList":[[1721611800000,1721620800000],[1721624400000,1721635200000]],"volumeRatio":0.452878,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/02257/tweets","defaultTab":"tweets","newsList":[{"id":"2453566347","title":"圣诺医药-B07月22日遭主力抛售42万元 环比增加110.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2453566347","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2453566347?lang=zh_cn&edition=full","pubTime":"2024-07-22 16:16","pubTimestamp":1721636209,"startTime":"0","endTime":"0","summary":"07月22日, 圣诺医药-B股价涨0.64%，报收4.74元，成交金额240万元，换手率0.58%，振幅4.67%，量比0.45。圣诺医药-B今日主力资金净流出42万元，上一交易日主力净流出20万元，今日环比增加110.00%。该股近5个交易日下跌8.32%，主力资金累计净流出85万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入235万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072216172495e79ba8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024072216172495e79ba8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2452556532","title":"18A市值半年考！君圣泰、圣诺医药跌幅近九成，科伦博泰、复宏汉霖、亚盛医药涨幅前三","url":"https://stock-news.laohu8.com/highlight/detail?id=2452556532","media":"医药经济报","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452556532?lang=zh_cn&edition=full","pubTime":"2024-07-20 13:31","pubTimestamp":1721453482,"startTime":"0","endTime":"0","summary":"截至7月19日中午，近半年来，总市值跌幅最大的十家企业分别是君圣泰医药、圣诺医药、健世科技、来凯医药、创胜集团、润迈德、康宁杰瑞制药、宜明昂科、德琪医药和兆科眼科。截至公告发布之日，圣诺医药仅赎回了20万美元。截至7月19日中午，科伦博泰、复宏汉霖、亚盛医药、欧康维视生物和东曜药业近半年总市值","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407201333569f6fe90d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407201333569f6fe90d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02105","BK1515","02257","09939","01875","02511","06855","BK1161","02696","09877","06628","BK1574"],"gpt_icon":0},{"id":"2452182103","title":"圣诺医药-B07月17日遭主力抛售17万元 环比增加142.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2452182103","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2452182103?lang=zh_cn&edition=full","pubTime":"2024-07-17 16:16","pubTimestamp":1721204191,"startTime":"0","endTime":"0","summary":"07月17日, 圣诺医药-B股价跌1.62%，报收4.85元，成交金额370万元，换手率0.86%，振幅4.06%，量比0.16。圣诺医药-B今日主力资金净流出17万元，上一交易日主力净流出7万元，今日环比增加142.86%。该股近5个交易日下跌2.22%，主力资金累计净流入123万元；近20日主力资金累计净流入216万元，其中净流入天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071716170995cd6c98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024071716170995cd6c98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2451938865","title":"圣诺医药-B盘中异动 股价大跌5.03%报4.910港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2451938865","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451938865?lang=zh_cn&edition=full","pubTime":"2024-07-16 10:43","pubTimestamp":1721097817,"startTime":"0","endTime":"0","summary":"2024年07月16日早盘10时43分，圣诺医药-B股票出现异动，股价大幅下挫5.03%。截至发稿，该股报4.910港元/股，成交量91.23万股，换手率1.04%，振幅13.35%。资金方面，该股资金流入124.512万港元，流出246.474万港元。圣诺医药-B股票所在的生物技术行业中，整体涨幅为0.01%。圣诺医药-B公司简介：Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716104338941f7424&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240716104338941f7424&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2451938501","title":"圣诺医药－Ｂ(02257)股价显著波动13.346%，现价港币$4.91","url":"https://stock-news.laohu8.com/highlight/detail?id=2451938501","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451938501?lang=zh_cn&edition=full","pubTime":"2024-07-16 10:43","pubTimestamp":1721097780,"startTime":"0","endTime":"0","summary":"[异动股]圣诺医药－Ｂ(02257) 股价在上午10:43出现显著波动13.346%，现股价为港币$4.91，比前收市价下跌5.029%5.029%。至目前为止，今日最高价为$5.6，而最低价为$4.91。总成交量为89.87万股，总成交金额为港币$463.126万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180112134424260_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180112134424260_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAC24071612/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2451293854","title":"圣诺医药－Ｂ(02257)股价下跌5.029%，现价港币$4.91","url":"https://stock-news.laohu8.com/highlight/detail?id=2451293854","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2451293854?lang=zh_cn&edition=full","pubTime":"2024-07-16 10:43","pubTimestamp":1721097780,"startTime":"0","endTime":"0","summary":"[下跌股]圣诺医药－Ｂ(02257) 股价在上午10:43比前收市价下跌5.029%，现股价为港币$4.91。至目前为止，今日最高价为$5.6，而最低价为$4.91。总成交量为88.52万股，总成交金额为港币$456.486万。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180126135511023_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2407161589/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2450581713","title":"圣诺医药2000万美元私募基金投资或血本无归","url":"https://stock-news.laohu8.com/highlight/detail?id=2450581713","media":"中国经营网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450581713?lang=zh_cn&edition=full","pubTime":"2024-07-12 19:54","pubTimestamp":1720785254,"startTime":"0","endTime":"0","summary":"屋漏偏逢连天雨。继大股东质押股权被强制平仓、高管相继离职之后，圣诺医药（2257.HK）日前又在投资基金上遭遇“黑天鹅”。7月8日，港股上市公司圣诺医药发布公告称，由于公司认购基金所投资的私募债发行人可能违约，预计投资基金的资产净值将发生重大不利变化。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202407123129970537.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2450130829","title":"圣诺医药-B07月12日主力资金流入63万元 连续5日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2450130829","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450130829?lang=zh_cn&edition=full","pubTime":"2024-07-12 16:15","pubTimestamp":1720772157,"startTime":"0","endTime":"0","summary":"07月12日, 圣诺医药-B股价涨8.67%，报收5.39元，成交金额3166万元，换手率6.71%，振幅17.54%，量比1.39。圣诺医药-B今日主力资金净流入63万元，连续5日净流入，上一交易日主力净流入32万元，今日环比增加96.88%。该股近5个交易日上涨32.76%，主力资金累计净流入318万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流入133万元，其中净流入天数为9日。该股主力净额占比0.14%，港股市场排名32/2647。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121616129f3a5f4c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407121616129f3a5f4c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2450303481","title":"Sirnaomics宣布完成针对靶向APOC3用于治疗心血管疾病的STP125G在非人灵长类动物模型中安全性和有效性的IND准备阶段研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2450303481","media":"美通社","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450303481?lang=zh_cn&edition=full","pubTime":"2024-07-12 16:12","pubTimestamp":1720771920,"startTime":"0","endTime":"0","summary":"使用siRNA或反义寡核苷酸下调载脂蛋白C3已被证明能有效降低严重高甘油三酯血症患者的甘油三酯。Sirnaomics创始人、董事会主席、执行董事、总裁兼首席执行官陆阳博士表示：\"STP125G是基于我们的GalAhead mxRNA技术的第二个候选药物，它在非人灵长类动物模型中显示出卓越的安全性和强大的疗效。Sirnaomics是首家于亚洲和美国均拥有重要市场地位的临床阶段RNA疗法生物制药公司。STP125G是第二款基于Sirnaomics专利GalAhead mxRNA技术的siRNA治疗药物，以载脂蛋白C3 mRNA为靶点，用于心血管疾病的治疗。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://wwwold.prnasia.com/story/archive/4460218_ZH60218_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["TG","BK4153","BK1161","02257","PPT","BK4090"],"gpt_icon":0},{"id":"2450172320","title":"东曜药业-B盘中异动 下午盘急速上涨9.09%报2.041港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2450172320","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450172320?lang=zh_cn&edition=full","pubTime":"2024-07-12 13:21","pubTimestamp":1720761707,"startTime":"0","endTime":"0","summary":"2024年07月12日下午盘13时21分，东曜药业-B股票出现异动，股价大幅上涨9.09%。截至发稿，该股报2.041港元/股，成交量10000股，换手率0.00%，振幅0.00%。资金方面，该股资金流入2.04万港元，流出0港元。东曜药业-B股票所在的生物技术行业中，整体涨幅为1.21%。东曜药业-B公司简介：东曜药业股份有限公司是一家主要从事开发及商业化肿瘤药物及疗法的公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712132147af91fec2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712132147af91fec2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["01875","02257","BK1161","BK1574"],"gpt_icon":0},{"id":"2450324009","title":"圣诺医药(02257.HK)完成旗下一项心血管疾病药物IND准备阶段研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2450324009","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450324009?lang=zh_cn&edition=full","pubTime":"2024-07-12 12:24","pubTimestamp":1720758240,"startTime":"0","endTime":"0","summary":"圣诺医药－Ｂ(02257.HK) 公布，已完成针对靶点载脂蛋白C3(ApoC3)siRNA治疗药物STP125G的IND准备阶段研究，这是基于其专有的GalAhead mxRNA技术的第二个候选药物。非人灵长类动物(NHP)研究的安全性和有效性结果，有力地支持向美国FDA申请IND，以启动STP125G用于心血管疾病适应症的I期临床研究。公司不能保证STP125G药物最终将成功上市。(cy/w)(港股报价延迟最少十五分钟。)AASTOCKS新闻","market":"other","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20220513155537706_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20220513155537706_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1363267/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2450249393","title":"【港股通】圣诺医药(02257)已完成治疗药物STP125G的IND准备阶段研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2450249393","media":"金吾财讯","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450249393?lang=zh_cn&edition=full","pubTime":"2024-07-12 12:12","pubTimestamp":1720757557,"startTime":"0","endTime":"0","summary":"金吾财讯 | 圣诺医药 公布，已完成了针对靶点载脂蛋白C3的siRNA治疗药物STP125G的IND准备阶段研究，这是基于其专有的GalAhead mxRNA技术的第二个候选药物。非人灵长类动物研究的安全性和有效性结果有力地支持了向美国FDA申请IND，以启动STP125G用于心血管疾病适应症的I期临床研究。载脂蛋白C3是高甘油三酯血症与心血管疾病相关联的一个重要新兴靶点。ApoC3是许多已确定的心血管疾病风险因素的有效调节剂，存在于乳糜微粒、VLDL、LDL和HDL颗粒中。","market":"sg","thumbnail":"https://static.szfiu.com/news/20210810/OWQwNTk1YTkxMThhNDViMzhlZTk4MmY1MjNjNTJjMTgxNDI5NTA5OTg3NA==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/OWQwNTk1YTkxMThhNDViMzhlZTk4MmY1MjNjNTJjMTgxNDI5NTA5OTg3NA==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"1940291","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02257","BK1161","HSTECH","HSCEI","07226","YANG"],"gpt_icon":0},{"id":"2450321713","title":"圣诺医药-B(02257)：完成针对靶向APOC3用于治疗心血管疾病的STP125G 在非人灵长类动物模型中安全性和有效性的IND准备阶段研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2450321713","media":"智通财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450321713?lang=zh_cn&edition=full","pubTime":"2024-07-12 12:04","pubTimestamp":1720757067,"startTime":"0","endTime":"0","summary":"智通财经APP讯，圣诺医药-B 发布公告，集团基于其专有的GalAheadTM mxRNA技术，完成了针对靶向载脂蛋白C3 的siRNA治疗药物STP125G的IND准备阶段研究。非人灵长类动物研究的安全性和有效性结果有力地支持了集团向美国FDA申请IND，以启动STP125G用于心血管疾病适应症的I期临床研究。使用siRNA或反义寡核苷酸下调载脂蛋白C3已被证明能有效降低严重高甘油三酯血症患者的甘油三酯。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1149858.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2450421573","title":"圣诺医药-B盘中异动 早盘股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450421573","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450421573?lang=zh_cn&edition=full","pubTime":"2024-07-12 09:35","pubTimestamp":1720748132,"startTime":"0","endTime":"0","summary":"2024年07月12日早盘09时35分，圣诺医药-B股票出现波动，股价大幅拉升5.04%。圣诺医药-B股票所在的生物技术行业中，整体涨幅为0.30%。圣诺医药-B公司简介：Sirnaomics Ltd是一家投资控股公司。其主要临床候选药物包括STP705和STP707。2021年12月，圣诺医药在港交所上市，募资净额为3.96亿港元，被称为“中国核酸药物第一股”。截至目前，圣诺医药也未披露相关职务的继任公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712093532aef9526b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240712093532aef9526b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2450625678","title":"圣诺医药理财爆雷、荣昌生物股价失利，Biotech困在现金流里？","url":"https://stock-news.laohu8.com/highlight/detail?id=2450625678","media":"21财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450625678?lang=zh_cn&edition=full","pubTime":"2024-07-10 18:16","pubTimestamp":1720606568,"startTime":"0","endTime":"0","summary":"作为对比，截至2023年12月31日，圣诺医药的现金及现金等价物仅剩2388万美元。公开资料显示，这是国内Biotech在RNAi领域进行的首笔重大海外授权交易。圣诺医药在公告中表示，投资经理已对该事件采取相应措施，包括委聘审计师对私募债发行人的财务信息进行审计。不同于尚未有新药上市的圣诺医药，目前，荣昌生物已有维迪西妥单抗和泰它西普两款创新药获批上市。荣昌生物在年报中表示。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710181612959e108d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710181612959e108d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU2328871848.SGD","09995","BK1583","02257","BK1574","LU1969619763.USD","BK1161"],"gpt_icon":0},{"id":"2450857418","title":"圣诺医药-B07月10日主力资金流入87万元 连续3日加仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2450857418","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450857418?lang=zh_cn&edition=full","pubTime":"2024-07-10 16:16","pubTimestamp":1720599376,"startTime":"0","endTime":"0","summary":"07月10日, 圣诺医药-B股价涨14.55%，报收4.96元，成交金额5035万元，换手率11.56%，振幅25.87%，量比4.95。圣诺医药-B今日主力资金净流入87万元，连续3日净流入，上一交易日主力净流入107万元，今日环比减少18.69%。近一年数据显示，该股主力连续3日净流入后，次日上涨概率为33.33%，平均涨幅为1.22%。该股近5个交易日上涨14.92%，主力资金累计净流入194万元，其中1个交易日为股价下跌时净流入；近20日主力资金累计净流出70万元，其中净流出天数为9日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710161641959d3d92&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710161641959d3d92&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2450685528","title":"港股异动 | 圣诺医药-B(02257)盘中涨超25% STP122G抗凝治疗临床试验第二序列完成","url":"https://stock-news.laohu8.com/highlight/detail?id=2450685528","media":"智通财经网","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450685528?lang=zh_cn&edition=full","pubTime":"2024-07-10 14:52","pubTimestamp":1720594332,"startTime":"0","endTime":"0","summary":"圣诺医药-B(02257)盘中涨超25%，截至发稿，涨17.32%，报5.08港元，成交额4052.72万港元。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20240710/20240710145222_39693.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20240710/20240710145222_39693.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1148472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["03347","BK1576","YANG","HSTECH","BK1161","02257","HSCEI","BK1141","07226","BK1583"],"gpt_icon":0},{"id":"2450874528","title":"圣诺医药－Ｂ(02257)股价上升8.314%，现价港币$4.69","url":"https://stock-news.laohu8.com/highlight/detail?id=2450874528","media":"阿斯达克财经","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450874528?lang=zh_cn&edition=full","pubTime":"2024-07-10 10:14","pubTimestamp":1720577640,"startTime":"0","endTime":"0","summary":"[上升股]圣诺医药－Ｂ(02257) 股价在上午10:14比前收市价上升8.314%，现股价为港币$4.69。至目前为止，今日最高价为$4.69，而最低价为$4.33。总成交量为123.35万股，总成交金额为港币$561.274万。","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20180126133718217_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2407102103/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02257","BK1161"],"gpt_icon":0},{"id":"2450388178","title":"圣诺医药-B盘中异动 股价大涨5.31%","url":"https://stock-news.laohu8.com/highlight/detail?id=2450388178","media":"自选股智能写手","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450388178?lang=zh_cn&edition=full","pubTime":"2024-07-10 09:40","pubTimestamp":1720575640,"startTime":"0","endTime":"0","summary":"2024年07月10日早盘09时40分，圣诺医药-B股票出现异动，股价急速上涨5.31%。圣诺医药-B股票所在的生物技术行业中，整体跌幅为0.39%。其相关个股中，圣诺医药-B、云康集团、嘉和生物-B涨幅较大，振幅较大的相关个股有科伦博泰生物-B、药明巨诺-B、来凯医药-B，振幅分别为5.58%、5.35%、4.79%。2021年12月，圣诺医药在港交所上市，募资净额为3.96亿港元，被称为“中国核酸药物第一股”。截至目前，圣诺医药也未披露相关职务的继任公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710094040941f598e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240710094040941f598e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0},{"id":"2450009017","title":"圣诺医药理财“暴雷”损失或过亿，公司现金流早已告急","url":"https://stock-news.laohu8.com/highlight/detail?id=2450009017","media":"界面","labels":[],"top":-1,"share":"https://www.laohu8.com/m/news/2450009017?lang=zh_cn&edition=full","pubTime":"2024-07-09 16:39","pubTimestamp":1720514378,"startTime":"0","endTime":"0","summary":"圣诺医药自查最终能挽回多少损失仍是未知数。不过，圣诺医药的董事似乎不愿意与公司共苦。此外，圣诺医药大股东已遭强制平仓。3月18日，圣诺医药再次公告表示，执行董事戴晓畅再次因为保证金补缴要求未获满足，其持有的9.95万股股份已在3月15日被强制出售。该部分股份占圣诺医药股份的7.58%，倘未能提供令金融机构满意的还款计划，该部分股份也将被强制出售。截至目前，圣诺医药也未披露相关职务的继任公告。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407091641519f24457d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202407091641519f24457d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","02257"],"gpt_icon":0}],"profile":{"websiteUrl":"https://www.sirnaomics.com/en/","stockEarnings":[{"period":"1week","weight":-0.1262},{"period":"1month","weight":-0.1342},{"period":"3month","weight":-0.1879},{"period":"6month","weight":-0.8471},{"period":"1year","weight":-0.9133},{"period":"ytd","weight":-0.8684}],"compareEarnings":[{"period":"1week","weight":-0.0479},{"period":"1month","weight":-0.0549},{"period":"3month","weight":0.0736},{"period":"6month","weight":0.1378},{"period":"1year","weight":-0.0798},{"period":"ytd","weight":0.0217}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"圣诺医药有限公司是一家主要从事临床阶段的核糖核酸（RNA）治疗生物制药公司。该公司从事发现和开发具有未满足医疗需求和市场机会的适应症的药物。该公司的产品在各种市场疾病中具有广泛的治疗作用，包括肿瘤、纤维化相关疾病以及抗病毒和心脏代谢疾病。该公司的目标一旦根据明确的科学原理选定，就会根据其对核糖核酸干扰所涉及的生化机制的理解，应用算法来确定针对选定目标基因的候选核糖核酸干扰触发序列，并采用高通量流程来设计、筛选和测试未来的管道产品。该公司有五项正在进行的I/II期临床试验，另外至少有14种候选产品正在进行新药研究的启用或高级临床前研究。","exchange":"SEHK","name":"圣诺医药-B","nameEN":"SIRNAOMICS-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"圣诺医药-B(02257)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供圣诺医药-B(02257)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"圣诺医药-B,02257,圣诺医药-B股票,圣诺医药-B股票老虎,圣诺医药-B股票老虎国际,圣诺医药-B行情,圣诺医药-B股票行情,圣诺医药-B股价,圣诺医药-B股市,圣诺医药-B股票价格,圣诺医药-B股票交易,圣诺医药-B股票购买,圣诺医药-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"圣诺医药-B(02257)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供圣诺医药-B(02257)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}